Lappi M, Rajantie J, Uusitalo R J
Children's Hospital, Helsinki University Central Hospital, Finland.
Graefes Arch Clin Exp Ophthalmol. 1990;228(3):218-21. doi: 10.1007/BF00920023.
Chemotherapy and radiation produce a dose-dependent anti-leukemic effect. Combined chemoradiotherapy and bone marrow transplantation (BMT) were given in our clinic to treat children with acute leukemias. Total body irradiation of 10 Gy in a single dose was used. One long-term side effect of this treatment was the development of subcapsular cataract; this was seen in all nine long-term survivors of the 17 children with acute lymphoblastic (ALL) or acute myelogenous (AML) leukemia who were treated as described above. One year after marrow transplantation, all the eyes studied had visual acuity of 20/20 and an optically clear lens. Three years later, 60% of the eyes had visual acuity of less than 20/40 and all had posterior, subcapsular cataracts. The cataract in all cases was quite uniform, consisting of opacities in the posterior subcapsular region. Cataract formation was treatment-related and seemed to correlate only to the type of total body irradiation. We concluded that the cataracts seen in the present study were a late complication of allogeneic BMT and were specifically due to the single-dose total body irradiation.
化疗和放疗会产生剂量依赖性的抗白血病作用。我们诊所采用联合放化疗及骨髓移植(BMT)来治疗急性白血病患儿。单次全身照射剂量为10 Gy。这种治疗的一个长期副作用是出现晶状体后囊下白内障;在上述接受治疗的17例急性淋巴细胞白血病(ALL)或急性髓细胞白血病(AML)患儿的所有9例长期存活者中均可见到这种情况。骨髓移植后一年,所有接受检查的眼睛视力均为20/20,晶状体光学透明。三年后,60%的眼睛视力低于20/40,且全部出现后囊下白内障。所有病例中的白内障相当一致,均由后囊下区域的混浊组成。白内障形成与治疗相关,似乎仅与全身照射的类型有关。我们得出结论,本研究中所见的白内障是异基因BMT的晚期并发症,且具体是由于单次全身照射所致。